» Articles » PMID: 36389721

Biomarkers of Autoimmunity and Beta Cell Metabolism in Type 1 Diabetes

Overview
Journal Front Immunol
Date 2022 Nov 17
PMID 36389721
Authors
Affiliations
Soon will be listed here.
Abstract

Posttranslational protein modifications (PTMs) are an inherent response to physiological changes causing altered protein structure and potentially modulating important biological functions of the modified protein. Besides cellular metabolic pathways that may be dictated by PTMs, the subtle change of proteins also may provoke immune attack in numerous autoimmune diseases. Type 1 diabetes (T1D) is a chronic autoimmune disease destroying insulin-producing beta cells within the pancreatic islets, a result of tissue inflammation to specific autoantigens. This review summarizes how PTMs arise and the potential pathological consequence of PTMs, with particular focus on specific autoimmunity to pancreatic beta cells and cellular metabolic dysfunction in T1D. Moreover, we review PTM-associated biomarkers in the prediction, diagnosis and in monitoring disease activity in T1D. Finally, we will discuss potential preventive and therapeutic approaches of targeting PTMs in repairing or restoring normal metabolic pathways in pancreatic islets.

Citing Articles

Identification of unique cell type responses in pancreatic islets to stress.

Maestas M, Ishahak M, Augsornworawat P, Veronese-Paniagua D, Maxwell K, Velazco-Cruz L Nat Commun. 2024; 15(1):5567.

PMID: 38956087 PMC: 11220140. DOI: 10.1038/s41467-024-49724-w.


Natural isoaspartyl protein modification of ZAP70 alters T cell responses in lupus.

Yang M, Lam T, Kanyo J, Kang I, Zhou Z, Clarke S Autoimmunity. 2023; 56(1):2282945.

PMID: 37994408 PMC: 10897934. DOI: 10.1080/08916934.2023.2282945.


Exploration of Immune Targets for Type 1 Diabetes and Latent Autoimmune Disease Immunotherapy.

Siddiqui K, Nawaz S Immunotargets Ther. 2023; 12:91-103.

PMID: 37795196 PMC: 10546931. DOI: 10.2147/ITT.S417917.


Identification of Autoantibodies to a Hybrid Insulin Peptide in Type 1 Diabetes.

Wenzlau J, Gu Y, Michels A, Rewers M, Haskins K, Yu L Diagnostics (Basel). 2023; 13(17).

PMID: 37685398 PMC: 10487141. DOI: 10.3390/diagnostics13172859.


NOD mouse dorsal root ganglia display morphological and gene expression defects before and during autoimmune diabetes development.

Corral-Pujol M, Arpa B, Rosell-Mases E, Egia-Mendikute L, Mora C, Stratmann T Front Endocrinol (Lausanne). 2023; 14:1176566.

PMID: 37334284 PMC: 10272810. DOI: 10.3389/fendo.2023.1176566.

References
1.
Patel H, Chen J, Das K, Kavdia M . Hyperglycemia induces differential change in oxidative stress at gene expression and functional levels in HUVEC and HMVEC. Cardiovasc Diabetol. 2013; 12:142. PMC: 3851327. DOI: 10.1186/1475-2840-12-142. View

2.
Herold K, Bundy B, Long S, Bluestone J, DiMeglio L, Dufort M . An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes. N Engl J Med. 2019; 381(7):603-613. PMC: 6776880. DOI: 10.1056/NEJMoa1902226. View

3.
Tilvawala R, Nguyen S, Maurais A, Nemmara V, Nagar M, Salinger A . The Rheumatoid Arthritis-Associated Citrullinome. Cell Chem Biol. 2018; 25(6):691-704.e6. PMC: 6014894. DOI: 10.1016/j.chembiol.2018.03.002. View

4.
Mamula M, Gee R, Elliott J, Sette A, Southwood S, Jones P . Isoaspartyl post-translational modification triggers autoimmune responses to self-proteins. J Biol Chem. 1999; 274(32):22321-7. DOI: 10.1074/jbc.274.32.22321. View

5.
Takahara H, Okamoto H, Sugawara K . Affinity chromatography of peptidylarginine deiminase from rabbit skeletal muscle on a column of soybean trypsin inhibitor (Kunitz)-Sepharose. J Biochem. 1986; 99(5):1417-24. DOI: 10.1093/oxfordjournals.jbchem.a135611. View